Detalhe da pesquisa
1.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094839
2.
Statistical Approaches for Establishing Appropriate Immunogenicity Assay Cut Points: Impact of Sample Distribution, Sample Size, and Outlier Removal.
AAPS J
; 25(3): 37, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016171